Long-Term Valproate Hematologic Side Effects

Abstract

Hematologic side effects in 60 patients, aged 2-29 years (mean 14 years), receiving valproate (VPA) monotherapy for >4 years in a long-term care facility, are reported from the Department of Pediatrics, East Carolina University School of Medicine, Greenville, North Carolina.

Keywords

• valproate
• thrombocytopenia
• hematologic abnormalities